Burton, D. R., Stanfield, R. L., and Wilson, I. A. (2005). Antibody vs. HIV
The current vaccination schedule calls for three injec-
in a clash of evolutionary titans. Proc. Natl. Acad. Sci. U.S.A. 102:
tions of S protein over a period of 6 months. Further
boosting, assessed by anti-HBV titers in serum, may be
Coskun, A. K., van Maanen, M., Nguyen, V., and Sutton, R. E. (2006).
necessary to achieve adequate immunity. These vaccines
Human chromosome 2 carries a gene required for production of infec-
are quite effective if received prior to exposure or shortly
tious human immunodeficiency virus type I. J. Virol. 80: 3406­3415.
Cullen, B. R. (1998). Posttranscriptional regulation by the HIV-1 Rev
after infection (the incubation period of HBV is quite long,
protein. Semin. Virol. 8: 327­334.
as noted earlier). They are unable to eliminate the infec-
Desrosiers, R. C. (2006). Nonhuman lentiviruses. Chapter 59 in: Fields
tion in a chronically infected individual, however. Adults
Virology, Fifth Edition (D. M. Knipe and P. M. Howley, Eds. in chief),
in high-risk groups, such as medical personnel, laboratory
Philadelphia, Lippincott Williams & Wilkins, pp. 2215­2244.
personnel who handle potentially infected blood samples,
Freed, E. O. (1998). HIV-1 Gag proteins: diverse functions in the virus life
cycle--minireview. Virology 251: 1­15.
sexually active individuals, drug users who inject drugs, or
Heeney, J. L., Dalgleish, A. G., and Weiss, R. A. (2006). Origin of HIV and
individuals in ethnic groups that have a high incidence of
the evolution of resistance to AIDS. Science 313: 462­466.
HBV such as Alaskan natives, are encouraged to become
Huthoff, H., and Malim, M. H. (2005). Cytidine deamination and resis-
vaccinated. Vaccination of all infants at birth is also recom-
tance to retroviral infection: towards a structural understanding of the
mended by the American Academy of Pediatricians. One
APOBEC proteins. Virology 334: 147­153.
Kuritzkes, D. R., and Walker, B. D. (2006). HIV-1 pathogenesis, clinical
reason for vaccination of infants is to prevent the establish-
manifestations and treatment. Chapter 58 in: Fields Virology, Fifth
ment of chronic infection in babies born to infected mothers.
Edition (D. M. Knipe and P. M. Howley, Eds. in chief), Philadelphia,
Immunization of infants starting within 12 hours of birth and
Lippincott Williams & Wilkins, pp. 2187­2214.
going through three or four shots has proved to be effective
Leitner, T., and Albert, J. (1999). The molecular clock of HIV-1 unveiled
in preventing chronic HBV infection even in infants that
through analysis of a known transmission history. Proc. Natl. Acad. Sci.
U.S.A. 96: 10752­10757.
would otherwise have become chronically infected (born to
Persaud, D., Zhou, Y., Siliciano, J. M., and Siliciano, R. F. (2003). Latency
mothers positive for HBsAg). Vaccination of infants is also
in human immunodeficiency virus type I infection: no easy answers.
recommended in an effort to eventually eliminate the virus
J. Virol. 77: 1659­1665.
from the human population. Because chronic infection of
Riddler, S. A., and Mellors, J. W. (1997). HIV-1 viral load and clinical
neonates is a major reservoir of the virus in nature, elimina-
outcome: review of recent studies. AIDS 11: S141­S148.
Saad, J. S., Miller, J., Tai, J., Kim, A., Ghanam, R. H., and Summers, M. F.
tion of this source of the virus could lead to the eradication
(2006). Structural basis for targeting HIV-1 gag proteins to the plasma mem-
of the virus in the human population. Many countries have
brane for virus assembly. Proc. Natl. Acad. Sci. U.S.A. 103: 11364­11369.
now initiated programs to immunize infants, and the current
Si, Z., Vandegraaff, N., O'hUigin, C., et al. (2006). Evolution of a cyto-
status of vaccination against HBV on a worldwide scale is
plasmic tripartite motif (TRIM) protein in cows that restricts retroviral
shown in Fig. 6.31.
infection. Proc. Natl. Acad. Sci. U.S.A. 103: 7454­7459.
United Nations Development Programme (2004). Thailand's Response to
HIV/AIDS: Progress and Challenges.
Whetter, L. E., Ojukwu, I. C., Novembre, F. J., and Dewhurst, S. (1999).
Pathogenesis of simian immunodeficiency virus infection. J. Gen. Virol.
80: 1557­1568.
Biology of Retroviruses
Zhu, P., Liu, J., Bess, J., Jr., et al. (2006). Distribution and three-dimensional
structure of AIDS virus envelope spikes. Nature 441: 847­852.
Coffin, J. M., Hughes, S. H., and Varmus, H. E. (Eds.) (1997). Retroviruses.
Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press.
Goff, S. P. (2006). Retroviridae: The retroviruses and their replica-
Foamy Viruses
tion. Chapter 55 in: Fields Virology, Fifth Edition (D. M. Knipe and
P. M. Howley, Eds. in chief), Philadelphia, Lippincott Williams &
Lecellier, C.-H., Neves, M., Giron, M.-L., Tobaly-Tapiero, J., and Saïb, A.
Wilkins, pp. 1999­2070.
(2002). Further characterization of equine foamy virus reveals unusual
Herniou, E., Martin, J., Miller, K., et al. (1998). Retroviral diversity and
features among the foamy viruses. J. Virol. 76: 7220­7227.
distribution in vertebrates. J. Virol. 72: 5955­5966.
Linial, M. (2006). Foamy viruses. Chapter 60 in: Fields Virology, Fifth
Hindmarsh, P., and Leis, J. (1999). Retroviral DNA integration. Microbiol.
Edition (D. M. Knipe and P. M. Howley, Eds. in chief), Philadelphia,
Mol. Biol. Rev. 63: 836­843.
Lippincott Williams & Wilkins, pp. 2245­2262.
Holzschu, D. L., Martineau, D., Fodor, S. K., et al. (1995). Nucleotide
sequence and protein analysis of a complex piscine retrovirus: walleye
dermal sarcoma virus. J. Virol. 69: 5320­5331.
Retroelements and Endogenous Retrovirus
Lairmore, M. D., and Franchini, F. (2006). Human T-Cell leukemia
virus Types 1 and 2. Chapter 56 in: Fields Virology, Fifth Edition
(D. M. Knipe and P. M. Howley, Eds. in chief), Philadelphia, Lippincott
Eickbush, T. H. (1994). Origin and evolutionary relationships of retro-
Williams & Wilkins, pp. 2071­2106.
elements. In The Evolutionary Biology of Viruses (S. S. Morse, Ed.),
New York, Raven Press, pp. 121­157.
Jern, P., Sperber, G. O., and Blomberg, J. (2006). Divergent patterns of
Lentiviruses and HIV/AIDS
recent retroviral integrations in the human and chimpanzee genomes:
probable transmissions between other primates and chimpanzees.
Berson, J. F., and Doms, R. W. (1998). Structure-function studies of the
J. Virol. 80: 1367­1375.
HIV-1 coreceptors. Semin. Immunol. 10: 237­248.
Rabe, B., Vlachou, A., Panté, N., Helenius, A., and Kann, M. (2003).
Medstrand, P., van de Lagemaat, L. N., Dunn, C. A., et al. (2005). Impact of
Nuclear import of hepatitis B virus capsids and release of the viral
transposable elements on the evolution of mammalian gene regulation.
genome. Proc. Natl. Acad. Sci. U.S.A. 100: 9849­9854.
Cytogenet. Genome Res. 110: 342­352.
Seeger, C., Zoulim, F., and Mason, W. S. (2006). Hepadnaviruses. Chapter
76 in: Fields Virology, Fifth Edition (D. M. Knipe and P. M. Howley,
Eds. in chief), Philadelphia, Lippincott Williams & Wilkins, pp.
Buckwold, V. E., and Ou, J.-H. (1999). Hepatitis B C-gene expression and
Tavis, J. E. (1996). The replication strategy of the hepadnaviruses. Viral
function: the lessons learned from viral mutants. Curr. Top. Virol. 1:
Hepatitis Rev. 2: 205­218.
Xu, Z., Yen, T. S. B., Wu, L., et al. (2002). Enhancement of hepatitis
Feitelson, M. A. (1999). Hepatitis B in hepatocarcinogenesis. J. Cell.
B virus replication by its X protein in transgenic mice. J. Virol. 76:
Physiol. 181: 188­202.
Lin, L., Prassolov, A., Funk, A., et al. (2005). Evidence from nature:
Yen, T. S. B. (1998). Posttranscriptional regulation of gene expression in
interspecies spread of heron hepatitis B viruses. J. Gen. Virol. 86:
hepadnaviruses. Semin. Virol. 8: 319­326.
Ou, J.-H. J. (Ed.) (2001) Hepatitis Viruses, The Netherlands, Kluwer
Academic Publishers.
Search WWH :
Custom Search
Previous Page
Viruses And Human Disease Topic Index
Next Page
Viruses And Human Disease Bookmarks